Eur J Neurol

Myoclonus in patients with COVID-19: Findings of autoantibodies against brain structures in cerebrospinal fluid.

Lindqvist I, Cunningham JL, Mulder J, ..., Virhammar J, Kumlien E

Eur J Neurol 30 (10) 3142-3148 [2023-10-00; online 2023-07-13]

Category: Biochemistry Funder: VR Type: Journal article

The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies.

Rabenstein M, Thomas OG, Carlin G, ..., Olsson T, Hessa T

Eur J Neurol - (-) - [2023-07-31; online 2023-07-31]

Category: Vaccines Funder: VR Type: Journal article

B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.

Asplund Högelin K, Ruffin N, Pin E, ..., Piehl F, Al Nimer F

Eur J Neurol 29 (11) 3317-3328 [2022-11-00; online 2022-07-20]

Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab Funder: VR Research Area: Vaccine Type: Journal article

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.

Virhammar J, Nääs A, Fällmar D, ..., Kumlien E, Rostami E

Eur J Neurol 28 (10) 3324-3331 [2021-10-00; online 2021-01-19]

Category: Health Funder: KAW/SciLifeLab Funder: VR Research Area: Biobanks for COVID-19 research Type: Journal article

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.

van de Munckhof A, Krzywicka K, Aguiar de Sousa D, ..., Ferro JM, Coutinho JM

Eur J Neurol - (-) - [2021-09-18; online 2021-09-18]

Category: Drug Discovery Category: Health Category: Vaccines Type: Journal article

Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.

Krzywicka K, Heldner MR, Sánchez van Kammen M, ..., Coutinho JM, Ferro JM

Eur J Neurol - (-) - [2021-07-22; online 2021-07-22]

Type: Review